{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:44:51Z","timestamp":1767141891057,"version":"build-2238731810"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"DOI":"10.1007\/s11657-024-01476-2","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T02:59:08Z","timestamp":1731985148000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Acquired hypophosphatemic osteomalacia: case series from a Peruvian referral center (1999\u20132023)"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2851-3727","authenticated-orcid":false,"given":"Jos\u00e9","family":"Paz-Ibarra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sof\u00eda","family":"S\u00e1enz-Bustamante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Inostroza-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola Sifuentes","family":"Hermenegildo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana Ancajima","family":"Lescano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9719-1875","authenticated-orcid":false,"given":"Marcio","family":"Concepci\u00f3n-Zavaleta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Rom\u00e1n-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo Adolfo","family":"Reza-Albarr\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,19]]},"reference":[{"issue":"2","key":"1476_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3803\/EnM.2023.1908","volume":"39","author":"N Ito","year":"2024","unstructured":"Ito N, Hidaka N, Kato H (2024) Acquired forms of fibroblast growth factor 23-related hypophosphatemic osteomalacia. Endocrinol Metab (Seoul) 39(2):255\u2013261. https:\/\/doi.org\/10.3803\/EnM.2023.1908","journal-title":"Endocrinol Metab (Seoul)"},{"key":"1476_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000866","author":"Y Takashi","year":"2024","unstructured":"Takashi Y, Kawanami D, Fukumoto S (2024) Recent advances in fibroblast growth factor 23-related hypophosphatemic disorders. Curr Opin Endocrinol Diabetes Obes. https:\/\/doi.org\/10.1097\/MED.0000000000000866","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"1476_CR3","doi-asserted-by":"publisher","first-page":"101144","DOI":"10.1016\/j.bonr.2021.101144","volume":"15","author":"N Hidaka","year":"2021","unstructured":"Hidaka N, Kato H, Koga M et al (2021) Induction of FGF23-related hypophosphatemic osteomalacia by alcohol consumption. Bone Reports 15:101144. https:\/\/doi.org\/10.1016\/j.bonr.2021.101144","journal-title":"Bone Reports"},{"issue":"10","key":"1476_CR4","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1001\/jama.294.10.1260","volume":"294","author":"SM Jan de Beur","year":"2005","unstructured":"Jan de Beur SM (2005) Tumor-induced osteomalacia. JAMA 294(10):1260. https:\/\/doi.org\/10.1001\/jama.294.10.1260","journal-title":"JAMA"},{"issue":"5","key":"1476_CR5","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.beem.2018.06.004","volume":"32","author":"M Christov","year":"2018","unstructured":"Christov M, J\u00fcppner H (2018) Phosphate homeostasis disorders. Best Pract Res Clin Endocrinol Metab 32(5):685\u2013706. https:\/\/doi.org\/10.1016\/j.beem.2018.06.004","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1476_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2017.44","volume":"3","author":"S Minisola","year":"2017","unstructured":"Minisola S, Peacock M, Fukumoto S et al (2017) Tumour-induced osteomalacia. Nat Rev Dis Prim 3:1\u201315. https:\/\/doi.org\/10.1038\/nrdp.2017.44","journal-title":"Nat Rev Dis Prim"},{"issue":"10","key":"1476_CR7","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/ncpendmet0639","volume":"3","author":"F Halperin","year":"2007","unstructured":"Halperin F, Anderson RJ, Mulder JE (2007) Tumor-induced osteomalacia: the importance of measuring serum phosphorus levels. Nat Clin Pract Endocrinol Metab 3(10):721\u2013725. https:\/\/doi.org\/10.1038\/ncpendmet0639","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"1","key":"1476_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12891-017-1632-5","volume":"18","author":"QY Zuo","year":"2017","unstructured":"Zuo QY, Wang H, Li W et al (2017) Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients. BMC Musculoskelet Disord 18(1):1\u20139. https:\/\/doi.org\/10.1186\/s12891-017-1632-5","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"1476_CR9","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jor.2016.12.010","volume":"14","author":"A Satyaraddi","year":"2017","unstructured":"Satyaraddi A, Cherian KE, Shetty S et al (2017) Musculoskeletal oncogenic osteomalacia\u2013an experience from a single centre in South India. J Orthop 14(1):184\u2013188. https:\/\/doi.org\/10.1016\/j.jor.2016.12.010","journal-title":"J Orthop"},{"issue":"5","key":"1476_CR10","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1177\/0300060519844979","volume":"47","author":"Y Qian","year":"2019","unstructured":"Qian Y, Dai Z, Zhu C et al (2019) Tumor-induced osteomalacia with the culprit lesion located in the palm: a case report. J Int Med Res 47(5):2240\u20132247. https:\/\/doi.org\/10.1177\/0300060519844979","journal-title":"J Int Med Res"},{"issue":"2","key":"1476_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1023\/A:1010006811394","volume":"2","author":"MK Drezner","year":"2001","unstructured":"Drezner MK (2001) Tumor-Induced Osteomalacia. Rev Endocr Metab Disord 2(2):175\u2013186. https:\/\/doi.org\/10.1023\/A:1010006811394","journal-title":"Rev Endocr Metab Disord"},{"issue":"xxxx","key":"1476_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.metabol.2019.01.006","volume":"103","author":"J Bacchetta","year":"2020","unstructured":"Bacchetta J, Bardet C, Pri\u00e9 D (2020) Physiology of FGF23 and overview of genetic diseases associated with renal phosphate wasting. Metabolism. 103(xxxx):1\u20137. https:\/\/doi.org\/10.1016\/j.metabol.2019.01.006","journal-title":"Metabolism."},{"issue":"3","key":"1476_CR13","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1359\/jbmr.040134","volume":"19","author":"T Shimada","year":"2004","unstructured":"Shimada T, Hasegawa H, Yamazaki Y et al (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19(3):429\u2013435. https:\/\/doi.org\/10.1359\/jbmr.040134","journal-title":"J Bone Miner Res"},{"issue":"3","key":"1476_CR14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/joim.13593","volume":"293","author":"SM Jan de Beur","year":"2023","unstructured":"Jan de Beur SM, Minisola S, Xia W et al (2023) Global guidance for the recognition, diagnosis, and management of tumor-induced osteomalacia. J Intern Med 293(3):309\u201328. https:\/\/doi.org\/10.1111\/joim.13593","journal-title":"J Intern Med"},{"issue":"2","key":"1476_CR15","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/ckj\/sfu004","volume":"7","author":"A Amblee","year":"2014","unstructured":"Amblee A, Uy J, Senseng C et al (2014) Tumor-induced osteomalacia with normal systemic fibroblast growth factor-23 level. Clin Kidney J 7(2):186\u2013189. https:\/\/doi.org\/10.1093\/ckj\/sfu004","journal-title":"Clin Kidney J"},{"issue":"11","key":"1476_CR16","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1002\/jbmr.4702","volume":"37","author":"IR Hartley","year":"2022","unstructured":"Hartley IR, Gafni RI, Roszko KL et al (2022) Determination of FGF23 levels for the diagnosis of FGF23-mediated hypophosphatemia. J Bone Miner Res 37(11):2174\u20132185. https:\/\/doi.org\/10.1002\/jbmr.4702","journal-title":"J Bone Miner Res"},{"issue":"4","key":"1476_CR17","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/MNM.0000000000001157","volume":"41","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, Hou G, Cheng W (2020) Performance of 68Ga-DOTA-SST PET\/CT, octreoscan SPECT\/CT and 18F-FDG PET\/CT in the detection of culprit tumors causing osteomalacia: a meta-analysis. Nucl Med Commun 41(4):370\u2013376. https:\/\/doi.org\/10.1097\/MNM.0000000000001157","journal-title":"Nucl Med Commun"},{"issue":"9308","key":"1476_CR18","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S0140-6736(02)07828-6","volume":"359","author":"SM Jan de Beur","year":"2002","unstructured":"Jan de Beur SM, Streeten EA, Civelek AC et al (2002) Localisation of mesenchymal tumours by somatostatin receptor imaging. Lancet 359(9308):761\u20133. https:\/\/doi.org\/10.1016\/S0140-6736(02)07828-6","journal-title":"Lancet"},{"issue":"7","key":"1476_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30276-6","volume":"19","author":"E Mumford","year":"2018","unstructured":"Mumford E, Marks J, Wagner T et al (2018) Oncogenic osteomalacia: diagnosis, localisation, and cure. Lancet Oncol 19(7):e365. https:\/\/doi.org\/10.1016\/S1470-2045(18)30276-6","journal-title":"Lancet Oncol"},{"issue":"3","key":"1476_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/RLU.0000000000002454","volume":"44","author":"X Shi","year":"2019","unstructured":"Shi X, Jing H, Li F et al (2019) 99mTc-HYNIC-TOC in the evaluation of recurrent tumor-induced osteomalacia. Clin Nucl Med 44(3):209\u2013213. https:\/\/doi.org\/10.1097\/RLU.0000000000002454","journal-title":"Clin Nucl Med"},{"issue":"8","key":"1476_CR21","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1002\/jbmr.4148","volume":"37","author":"N Hidaka","year":"2020","unstructured":"Hidaka N, Koga M, Kimura S et al (2020) Clinical challenges in diagnosis, tumor localization and treatment of tumor-induced osteomalacia: outcome of a retrospective surveillance. J Bone Miner Res 37(8):1479\u20131488. https:\/\/doi.org\/10.1002\/jbmr.4148","journal-title":"J Bone Miner Res"},{"issue":"4","key":"1476_CR22","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00223-022-01005-8","volume":"111","author":"A Bosman","year":"2022","unstructured":"Bosman A, Palermo A, Vanderhulst J et al (2022) Tumor-induced osteomalacia: a systematic clinical review of 895 cases. Calcif Tissue Int 111(4):367\u2013379. https:\/\/doi.org\/10.1007\/s00223-022-01005-8","journal-title":"Calcif Tissue Int"},{"key":"1476_CR23","doi-asserted-by":"publisher","unstructured":"Clunie GPR, Fox PE, Stamp TCB (2000) Four cases of acquired hypophosphataemic (\u2018oncogenic\u2019) osteomalacia. Problems of diagnosis, treatment and long-term management. Rheumatology 39(12):1415\u201321. https:\/\/doi.org\/10.1093\/rheumatology\/39.12.1415","DOI":"10.1093\/rheumatology\/39.12.1415"},{"issue":"2","key":"1476_CR24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s12105-016-0715-z","volume":"10","author":"H Qari","year":"2016","unstructured":"Qari H, Hamao-Sakamoto A, Fuselier C et al (2016) Phosphaturic Mesenchymal tumor: 2 new oral cases and review of 53 cases in the head and neck. Head Neck Pathol 10(2):192\u2013200. https:\/\/doi.org\/10.1007\/s12105-016-0715-z","journal-title":"Head Neck Pathol"},{"issue":"1","key":"1476_CR25","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s00223-020-00691-6","volume":"108","author":"P Florenzano","year":"2021","unstructured":"Florenzano P, Hartley IR, Jimenez M et al (2021) Tumor-induced osteomalacia. Calcif Tissue Int 108(1):128\u2013142. https:\/\/doi.org\/10.1007\/s00223-020-00691-6","journal-title":"Calcif Tissue Int"},{"key":"1476_CR26","unstructured":"US FDA (2020) FDA approves first therapy for rare disease that causes low phosphate blood levels, bone softening. FDA News Release. Availabe from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-therapy-rare-disease-causes-low-phosphate-blood-levels-bone-softening. Accessed 13 May 2024"},{"issue":"2","key":"1476_CR27","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/jbmr.4214","volume":"36","author":"Y Imanishi","year":"2021","unstructured":"Imanishi Y, Ito N, Rhee Y et al (2021) Interim analysis of a phase 2 open-label trial assessing burosumab efficacy and safety in patients with tumor-induced osteomalacia. J Bone Miner Res 36(2):262\u2013270. https:\/\/doi.org\/10.1002\/jbmr.4214","journal-title":"J Bone Miner Res"},{"issue":"4","key":"1476_CR28","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/jbmr.4257","volume":"36","author":"SM Jan de Beur","year":"2021","unstructured":"Jan de Beur SM, Miller PD, Weber TJ et al (2021) Burosumab for the treatment of tumor-induced osteomalacia. J Bone Miner Res 36(4):627\u201335. https:\/\/doi.org\/10.1002\/jbmr.4257","journal-title":"J Bone Miner Res"}],"updated-by":[{"DOI":"10.1007\/s11657-025-01583-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000}},{"DOI":"10.1007\/s11657-024-01481-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000}}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-024-01476-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11657-024-01476-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-024-01476-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T04:06:35Z","timestamp":1752552395000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11657-024-01476-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,19]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1476"],"URL":"https:\/\/doi.org\/10.1007\/s11657-024-01476-2","relation":{},"ISSN":["1862-3514"],"issn-type":[{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,19]]},"assertion":[{"value":"1 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Below is the original sentence that needs to be modified from the Discussion section (see attached files):","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"\"Among the causes of FGF-23-dependent acquired hypophosphatemic osteomalacia (AHO) are TIO, and other exogenous causes are intravenous iron preparations such as iron polymaltose and ferric carboxymaltose, some drugs that cause Fanconi syndrome, and alcohol consumption [2, 3]\".","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The sentence highlighted in yellow should be deleted (5th line of the first paragraph of the discussion)","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"If a clarifying sentence is needed, It would be as follows: \"Fanconi syndrome caused by some drugs can also cause hypophosphatemia, but by mechanisms not dependent on FGF-23.\"","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original article has been corrected.","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":12,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":13,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":14,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11657-025-01583-8","URL":"https:\/\/doi.org\/10.1007\/s11657-025-01583-8","order":15,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2024","order":16,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":17,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":18,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11657-024-01481-5","URL":"https:\/\/doi.org\/10.1007\/s11657-024-01481-5","order":19,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"116"}}